Trial · NCT03499873
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Nepafenac 0.3% Opthalmic Suspension | 183 | |
| Overall Study | STARTED | Ilevro 0.3% Opthalmic Suspension | 182 | |
| Overall Study | STARTED | Placebo (Vehicle) Opthalmic Suspension | 83 | |
| Overall Study | Safety Population | Nepafenac 0.3% Opthalmic Suspension | 175 | |
| Overall Study | Safety Population | Ilevro 0.3% Opthalmic Suspension | 174 | |
| Overall Study | Safety Population | Placebo (Vehicle) Opthalmic Suspension | 80 | |
| Overall Study | Per-Protocol Population | Nepafenac 0.3% Opthalmic Suspension | 144 | |
| Overall Study | Per-Protocol Population | Ilevro 0.3% Opthalmic Suspension | 143 | |
| Overall Study | Per-Protocol Population | Placebo (Vehicle) Opthalmic Suspension | 58 | |
| Overall Study | Modified-Intent-to-Treat | Nepafenac 0.3% Opthalmic Suspension | 170 | |
| Overall Study | Modified-Intent-to-Treat | Ilevro 0.3% Opthalmic Suspension | 168 | |
| Overall Study | Modified-Intent-to-Treat | Placebo (Vehicle) Opthalmic Suspension | 77 | |
| Overall Study | COMPLETED | Nepafenac 0.3% Opthalmic Suspension | 163 | |
| Overall Study | COMPLETED | Ilevro 0.3% Opthalmic Suspension | 162 | |
| Overall Study | COMPLETED | Placebo (Vehicle) Opthalmic Suspension | 56 | |
| Overall Study | NOT COMPLETED | Nepafenac 0.3% Opthalmic Suspension | 20 | |
| Overall Study | NOT COMPLETED | Ilevro 0.3% Opthalmic Suspension | 20 | |
| Overall Study | NOT COMPLETED | Placebo (Vehicle) Opthalmic Suspension | 27 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03499873/flow